Why this common muscle relaxant might turn your urine black, blue, or green
In short: Developed in 1956, methocarbamol remains a staple for treating acute musculoskeletal pain. While it is widely prescribed, its exact mechanism of action remains a mystery to medical science. Beyond its sedative effects, users are often surprised by its unusual side effects, including the potential for dramatic changes in urine color.
First introduced to the American market in 1957, methocarbamol was designed by A. H. Robins to improve upon the limited potency of mephenesin. Today, it is a common choice for managing short-term muscle spasms, often appearing in combination with other analgesics like ibuprofen or acetaminophen. Despite its long history of use, the drug's precise physiological impact is not fully understood. It is classified as a centrally acting relaxant, meaning it likely influences the central nervous system rather than acting directly on muscle tissue. Some animal research suggests it may block specific voltage-gated sodium channels, but this is likely only part of a complex, multifaceted mechanism.
The clinical evidence supporting methocarbamol is surprisingly thin. While it is frequently prescribed for back pain, research into its efficacy is often inconsistent. Comparative trials have shown it performs similarly to other common relaxants like cyclobenzaprine, yet it is often favored for being slightly less sedating. However, this does not eliminate risk. The drug is flagged by the 2012 Beers Criteria as potentially hazardous for older adults due to an increased risk of falls and fractures. Furthermore, it carries a range of side effects, from dizziness and blurred vision to the harmless but alarming discoloration of urine.
Safety profiles for the drug remain incomplete. Long-term studies regarding its potential for mutagenesis or cancer development have never been conducted, and its use in children under 16 is generally restricted to specific cases like tetanus. While it is considered to have a lower abuse potential than other carbamates, it still acts as a central nervous system depressant. When combined with alcohol, benzodiazepines, or opioids, it can lead to dangerous respiratory depression. Because its metabolism involves complex pathways, it requires caution in patients with kidney or liver issues, as these conditions can significantly extend the drug's half-life in the body.
Opens the Intellect+ feed with this card first. Swipe up for the next one.
Sources
- Summary by Intellect · source: Methocarbamol
To cite this card, link to https://intellectplus.co.uk/app/health-methocarbamol.
How we source, check and correct cards: Editorial standards.
General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.
Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?
Related
More in Health, medicine and disease · More in Health · Latest · A–Z · All topics
